Synapse - Works

Results (1636)

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: Beyond chemotherapy treatment

Review

Shahid, S.; Prockop, S. E.
Cancer Drug Resistance (2021)

Overall survival by best overall response with tabelecleucel in patients with Epstein-Barr virus-driven post-transplant lymphoproliferative disease following solid organ or allogeneic hematopoietic cell transplant

Meeting Abstract

Prockop, S.; Gamelin, L.; Dinavahi, R.; Sun, Y.; Zhao, W. Z.; Galderisi, F.; Mehta, A.
Blood (2021)

Fulltext@MSK | Save

Multicenter, open-label, phase 3 study of tabelecleucel for solid organ or allogeneic hematopoietic cell transplant recipients with Epstein-Barr virus-driven post transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE)

Meeting Abstract

Prockop, S.; Mahadeo, K. M.; Beitinjaneh, A.; Choquet, S.; Stiff, P.; Reshef, R.; Satyanarayana, G.; Dahiya, S.; Parmar, H.; Ye, W.; more...
Blood (2021)

Fulltext@MSK | Save

Metformin for treatment of cytopenias in children and young adults with Fanconi anemia

Meeting Abstract

Pollard, J. A.; Furutani, E. M.; Liu, S. S.; Esrick, E. B.; Cohen, L.; Bledsoe, J.; Lu, K.; Ramirez, M. J.; Surralles, J.; Malsch, M.; more...
Blood (2021)

Fulltext@MSK | Save

Ex vivo T-cell receptor αβ (+)/CD19 (+)depletion of peripheral stem cell grafts for pediatric patients with bone marrow failure (BMF) undergoing unrelated donor transplantation

Meeting Abstract

Oved, J. H.; Elgarten, C. W.; Wang, Y.; Kadauke, S.; Monos, D. S.; Barrett, D. M.; Grupp, S. A.; Bunin, N.; Olson, T. S.
Blood (2021)

Fulltext@MSK | Save

Pediatric patients with immune thrombocytopenic purpura have a dysbiotic gut microbiome at time of diagnosis

Meeting Abstract

Oved, J. H.; Elgarten, C. W.; Daniel, S. G.; Denu, L.; Silverman, M.; Bittinger, K.; Olson, T. S.; Lambert, M. P.
Blood (2021)

Fulltext@MSK | Save

Interim results of a pilot, prospective, randomized, double-blinded, vehicle- and comparator-controlled trial on safety and efficacy of a topical inhibitor of janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non- sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease

Meeting Abstract

Markova, A.; Pan, A.; Dusza, S.; Chowdhury, A.; Kukoyi, O.; Perales, M. A.; Lacouture, M.; Prockop, S.; Ponce, D. M.
Blood (2021)

Fulltext@MSK | Save

Racial disparities in access to alternative donor allografts persist in the era of "Donors for all"

Meeting Abstract

Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
Blood (2021)

Fulltext@MSK | Save

JSP191 As a single-agent conditioning regimen results in successful engraftment, donor myeloid chimerism, and production of donor derived naive lymphocytes in patients with severe combined immunodeficiency (SCID)

Meeting Abstract

Agarwa, R.; Dvorak, C. C.; Prockop, S.; Kwon, H. S.; Long-Boyle, J. R.; Le, A.; Brown, J. W.; Merkel, E.; Truong, K.; Velasco, B.; more...
Blood (2021)

Fulltext@MSK | Save

Outcomes of pediatric patients with therapy-related myeloid neoplasms

Journal Article

Sharma, A.; Huang, S.; Li, Y.; Brooke, R. J.; Ahmed, I.; Allewelt, H. B.; Amrolia, P.; Bertaina, A.; Bhatt, N. S.; Bierings, M. B.; more...
Bone Marrow Transplantation (2021)

Fulltext@MSK | Save